Core Scientific Shares Slip as Q1 Loss Overshadows Revenue
Core Scientific reports higher first-quarter revenue and gross profit, yet a net loss due to impairment charges derai...
Regular budget reassessment helps you adapt to life changes. Follow a simple schedule to review income, expenses, and goals.
22,166 articlesCore Scientific reports higher first-quarter revenue and gross profit, yet a net loss due to impairment charges derai...
Bitcoin jumped to a three-month high Friday as traders locked in gains. CryptoQuant data show a surge in realized pro...
A dramatic rise in gold shipments from the United States propelled exports to new highs in early 2026, signaling a sh...
Doximity is due to report Q4 results after the close, with analysts keyed to FY2027 guidance and margin trajectory as...
With the 2026 World Cup drawing millions to North America, specific ETFs positioned benefit from a sharp travel uptic...
A Senate committee greenlit the CLARITY Act in a 15-9 vote, sending the bill to the full chamber. Markets jumped as X...
In 2022, the S&P 500 plunged while a healthcare-focused ETF held its ground better than most. This story examines why...
Three S&P 500 value ETFs are outperforming growth peers in 2026, underscoring a market rotation that has yet to fully...
Johnson & Johnson and AbbVie report strong Q1 2026 results, showcasing two contrasting growth paths as biosimilar cha...
As inflation lingers and policy shifts loom, traders weigh a defensive, dividend-heavy pick trading under $50 against...
Solana enters a fresh momentum phase as ETF inflows surge and tokenized assets grow. Traders eye key resistance at $1...
Rambus navigates a cooling memory-chip cycle that could weigh on margins even as AI infrastructure demand remains a k...